×
模态框（Modal）标题
在这里添加一些文本
Close
Close
Submit
Cancel
Confirm
×
模态框（Modal）标题
×
Welcome to visit Clinical Medication Journal!
Quick Search
Nianqi Search
Adv Search
Toggle navigation
Home
About
Journal Information
办刊宗旨
Editorial Board
Office Platform
Announcement
Advertising
Dynamic
Subscription
Contact Us
A programmed death receptor-1 inhibitor——Tislelizumab
LIU Yi, LIU Qing, HUANG Lin, REN Xiao-lei, HUANG Jing, FENG Yu-fei
CLINICAL MEDICATION JOURNAL . 2022, (
1
): 37 -42 . DOI: 10.3969/j.issn.1672-3384.2022.01.004
